These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 31815374)

  • 21. Evolution of Length of Stay After Surgical and Transcatheter Aortic Valve Implantation Over 8 Years in 1,849 Patients >75 Years of Age and Comparison Between Transfemoral and Transsubclavian Transcatheter Aortic Valve Implantation.
    Anselmi A; Dachille A; Auffret V; Harmouche M; Roisne A; Bedossa M; Le Breton H; Verhoye JP
    Am J Cardiol; 2018 Oct; 122(8):1387-1393. PubMed ID: 30107906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
    Fink N; Segev A; Barbash I; Bogdan A; Hamdan A; Mazin I; Maor E; Hay I; Guetta V; Fefer P
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):341-6. PubMed ID: 26010839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transradial Secondary Access to Guide Valve Implantation and Manage Peripheral Vascular Complications During Transcatheter Aortic Valve Implantation.
    Jackson MWP; Muir DF; de Belder MA; Palmer S; Owens WA; Goodwin A; Hayat U; Williams PD
    Heart Lung Circ; 2019 Apr; 28(4):637-646. PubMed ID: 29685717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
    El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
    EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation.
    Frerker C; Schewel D; Kuck KH; Schäfer U
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):592-602. PubMed ID: 22707413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Fernandez-Lopez L; Chevalier B; Lefèvre T; Spaziano M; Unterseeh T; Champagne S; Benamer H; Sanguineti F; Garot P; Hovasse T
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1367-1373. PubMed ID: 30536569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N; De Palma R; Settergren M; Rück A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mid-Term Outcomes after Transapical and Transfemoral Transcatheter Aortic Valve Implantation for Aortic Stenosis and Porcelain Aorta with a Systematic Review of Transfemoral versus Transapical Approach.
    Useini D; Haldenwang P; Schlömicher M; Christ H; Naraghi H; Moustafine V; Strauch J
    Thorac Cardiovasc Surg; 2020 Oct; 68(7):623-632. PubMed ID: 31242522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Iliac Morphology Score Predicts Procedural Mortality and Major Vascular Complications in Transfemoral Aortic Valve Replacement.
    Blakeslee-Carter J; Dexter D; Mahoney P; Ahanchi S; Steerman S; Larion S; Cain B; Panneton JM
    Ann Vasc Surg; 2018 Jan; 46():208-217. PubMed ID: 28689947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Management of Percutaneous Transfemoral Access to Minimize Vascular Complications Related to Transcatheter Aortic Valve' Implantation.
    Lareyre F; Raffort J; Dommerc C; Habib Y; Bourlon F; Mialhe C
    Angiology; 2018 Feb; 69(2):143-150. PubMed ID: 28569069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Burzotta F; Aurigemma C; Romagnoli E; Shoeib O; Russo G; Zambrano A; Verdirosi D; Leone AM; Bruno P; Trani C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):459-470. PubMed ID: 31925991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors for Closure Failure following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
    Lee CH; Ko YG; Park Y; Shim CY; Hong GR; Lee SH; Lee S; Jung HW; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    Ann Vasc Surg; 2020 Jul; 66():406-414. PubMed ID: 31918036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical cutdown versus percutaneous access in transfemoral transcatheter aortic valve implantation: Insights from the Brazilian TAVI registry.
    Bernardi FL; Gomes WF; de Brito FS; Mangione JA; Sarmento-Leite R; Siqueira D; Carvalho LA; Tumelero R; Guerios EE; Lemos PA
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):501-5. PubMed ID: 25586633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease.
    Elbadawi A; Naqvi SY; Saad M; Elgendy IY; Mahmoud AA; Zainal A; Megaly M; Almahmoud MF; Altaweel A; Kleiman N; Abbott JD
    Cardiovasc Revasc Med; 2020 May; 21(5):604-609. PubMed ID: 31757744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Arora S; Vaidya SR; Strassle PD; Misenheimer JA; Rhodes JA; Ramm CJ; Wheeler EN; Caranasos TG; Cavender MA; Vavalle JP
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):806-812. PubMed ID: 29068166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Taramasso M; Denegri A; Kuwata S; Rickli H; Haager PK; Sütsch G; Rodriguez Cetina Biefer H; Kottwitz J; Nietlispach F; Maisano F
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):533-539. PubMed ID: 28500739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.